DuPont settles patent case with Bio-Rad Laboratories

NewsGuard 100/100 Score

DuPont has announced that it has settled patent infringement litigation against Bio-Rad Industries, Inc. of Hercules, Calif.

The patents-in-suit related to low-heat generating fluorometer devices usable in assays based on Polymerase Chain Reaction (PCR) technology, such as the award-winning BAX(R) System from DuPont Qualicon. Under the settlement, Bio-Rad was granted a non-exclusive license to the DuPont patents. Other terms of the settlement were not disclosed.

"DuPont has a long heritage and commitment to developing sustainable products for this industry," said Kevin Huttman, president of DuPont Qualicon. "To continue with future innovations, we must protect our investment in this technology through aggressive assertion of our patent rights when we believe they are being violated."

DuPont Qualicon sells DNA-based microbial detection systems covered by the DuPont patents under the trade name BAX(R) System. In the food industry, this system can be used to test samples for contamination with microorganisms. DuPont Qualicon recently received the 2006 North American Excellence in Technology Award from Frost & Sullivan in the field of pathogen detection for the development of its DNA-based BAX(R) system.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

The DuPont Oval Logo, DuPont(TM), The miracles of science(TM), and BAX(R) are registered trademarks or trademarks of DuPont or its affiliates.

http://www.dupont.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Baylor study reveals role of newly inherited DNA variants in recessive diseases